Category: 2021, No. 11

Interpretation of Clinical Guideline for Anti-vascular Endothelial Growth Factor Therapy of Retinopathy of Prematurity by Japanese Ophthalmological Society

Authors: Yang Xiaoyuan,  Cai Yuting,  Li Yun DOI: 10.3760/cma.j.cn115989-20210520-00313 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 1003-1009. Abstract                              [View PDF] [Read Full Text] Retinopathy of prematurity (ROP) is the leading cause of blindness in children worldwide.Intravitreal injection of anti-vascular endothelial growth factor (VEGF) […]

Role of IL-23/IL-17 pathway and regulatory network in the pathogenesis of uveitis

Authors: Yi Shenglan,  Yang Peizeng DOI: 10.3760/cma.j.cn115989-20191119-00500 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 1010-1016. Abstract                              [View PDF] [Read Full Text] Uveitis is an inflammatory disease, a leading cause of blindness, the pathogenesis of which is not fully understood.In recent years, it has […]

Insights into immune mechanisms of ocular graft-versus-host disease

Authors: Qiu Yuan,  Hong Jing DOI: 10.3760/cma.j.cn115989-20210922-00528 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 1017-1020. Abstract                              [View PDF] [Read Full Text] Ocular graft-versus-host disease (GVHD) is a major complication of hematopoietic stem cell transplantation (HSCT). However, the diagnostic criteria for ocular GVHD are […]

Role of retinal microglia-mediated parainflammation in age-related macular degeneration

Authors: Wang Yuwei,  Li Jing DOI: 10.3760/cma.j.cn115989-20210922-00526 Published 2021-11-10 Cite asChin J Exp Ophthalmol, 2021, 39(11): 1021-1024. Abstract                              [View PDF] [Read Full Text] Age-related macular degeneration (AMD) is a disease caused by multiple factors such as age, genetics and environmental risks.Inflammation plays an important role […]